Table 1:
Pathway | Target | Therapeutic Moiety |
---|---|---|
Wnt | Extracellular ligands | SFRP1 |
Frizzled receptor | Wnt5a | |
Wnt-C59 | ||
Anti-Frizzled7 antibody | ||
LRP 5/6 receptor | iWnt peptide | |
β-catenin | Niclosamide | |
IWR-1 | ||
KYA1797K | ||
FH535 | ||
siCTNNB1 | ||
siBag-1 | ||
iCRT 3/14 | ||
PNU-74654 | ||
Gigantol | ||
DANCR lncRNA | ||
β-catenin and c-Myc | miR-105 | |
IWP-2 | ||
DK419 | ||
miR-200c | ||
c-Myc | c-Myc shRNA | |
GSK-3β | Cromolyn | |
Pyrvinium pamoate | ||
Wnt-1 | siWnt-1 | |
Adavivint | ||
Wogonin | ||
Hh | Shh | Robotnikinin |
Anti-Shh 5E1 antibody | ||
Anti-Shh MEDI-5304 antibody | ||
Ptc1 | Ant-Patched-1 antibody | |
Smo | HhAntag | |
Cyclopamine | ||
Vismodegib | ||
DHCEO | ||
SMANT | ||
DY131 | ||
Itraconazole | ||
ALLO-1/2 | ||
Compound 5 | ||
Jervine | ||
Cur-61414 | ||
SANT 1–4 | ||
Saridegib | ||
Sonidegib | ||
TAK-441 | ||
BMS-833923 | ||
LEQ506 | ||
PF-04449913 | ||
LY2940680 | ||
Vitamin D3 | ||
BRD-6851 | ||
SEN450 | ||
MRT-83 | ||
Gli1 | Quinacrine | |
GANT61 | ||
GANT58 | ||
Arcyriaflavin C | ||
Physalins F | ||
siGli1 | ||
Gli1/2 | HPI1–4 | |
Gli-DNA binding | Anthothecol | |
Glabrescione B | ||
Arsenic trioxide | ||
Notch | ADAM 10/17 | INCB7839 |
INCB3619 | ||
INCB8765 | ||
KP457 | ||
GM6001 | ||
GI254023X | ||
8C7 antibody | ||
D1(A12) antibody | ||
A9(B8) antibody | ||
MEDI3622 antibody | ||
ADAM10 prodomain | ||
Rapamycin | ||
MAML1 | MAM peptide antagonist | |
SAHM1 | ||
Notch receptors | Notch-1 shRNA | |
Soluble Notch1 | ||
Soluble DLL1 | ||
Soluble Jagged1 | ||
Genistein | ||
Sulforaphane | ||
Quercetin | ||
Curcumin | ||
Resveratrol | ||
miR-34a | ||
Anti-Notch-1–3 antibody | ||
Jagged/Delta | siJagged1 antibody | |
Anti-DLL1–4 antibodies | ||
Nicastrin antibody | ||
DAPT | ||
MRK-560 | ||
MRK-003 | ||
PF-03084014 | ||
MK-0752 | ||
BMS-906024 | ||
DBZ (LY411575) | ||
LY450139 | ||
RO4929097 |